Outside US, Novartis Licenses First Ophthalmology Gene Therapy – Drug Discovery & Development
Drug Discovery & DevelopmentOutside US, Novartis Licenses First Ophthalmology Gene TherapyDrug Discovery & DevelopmentNovartis announced a licensing agreement with Spark Therapeutics covering development, registration and commercialization rights to vo… Continue reading
